BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24001199)

  • 1. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
    Wang H; Gao J; Bai M; Liu R; Li H; Deng T; Zhou L; Han R; Ge S; Huang D; Ba Y
    Platelets; 2014; 25(5):382-7. PubMed ID: 24001199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
    Man YN; Wang YN; Hao J; Liu X; Liu C; Zhu C; Wu XZ
    Int J Gynecol Cancer; 2015 Jan; 25(1):24-32. PubMed ID: 25347092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor.
    Guo Q; Zhang B; Dong X; Xie Q; Guo E; Huang H; Wu Y
    Pancreas; 2009 Apr; 38(3):e75-9. PubMed ID: 19276866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
    Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
    Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus.
    Takeuchi H; Ikeuchi S; Kitagawa Y; Shimada A; Oishi T; Isobe Y; Kubochi K; Kitajima M; Matsumoto S
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2222-7. PubMed ID: 18031385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of pretreatment plasma fibrinogen and platelet levels in patients with early-stage cervical cancer.
    Zhao K; Deng H; Qin Y; Liao W; Liang W
    Gynecol Obstet Invest; 2015; 79(1):25-33. PubMed ID: 25278089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of preoperative plasma fibrinogen level and platelet count in resectable esophageal squamous cell carcinoma.
    Wang J; Liu H; Shao N; Tan B; Song Q; Jia Y; Cheng Y
    World J Surg Oncol; 2015 Apr; 13():157. PubMed ID: 25896470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer.
    Son HJ; Park JW; Chang HJ; Kim DY; Kim BC; Kim SY; Park SC; Choi HS; Oh JH
    Ann Surg Oncol; 2013 Sep; 20(9):2908-13. PubMed ID: 23612884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M; Tajiri H
    Oncology; 2013; 85(5):269-77. PubMed ID: 24217119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.
    Feng Z; Wen H; Bi R; Duan Y; Yang W; Wu X
    BMC Cancer; 2016 Jan; 16():43. PubMed ID: 26817451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
    Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
    Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer.
    Ghezzi F; Cromi A; Siesto G; Giudici S; Serati M; Formenti G; Franchi M
    Gynecol Oncol; 2010 Nov; 119(2):309-13. PubMed ID: 20688365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
    BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic significance of coagulation assays in melanoma.
    Tas F; Ciftci R; Kilic L; Bilgin E; Keskin S; Sen F; Yildiz I; Yasasever V
    Melanoma Res; 2012 Oct; 22(5):368-75. PubMed ID: 22889867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiation of unresectable pancreatic carcinoma: impact of pretreatment hemoglobin level on patterns of failure.
    Morganti AG; Forni F; Macchia G; Valentini V; Smaniotto D; Trodella L; Balducci M; Cellini N
    Strahlenther Onkol; 2003 Feb; 179(2):87-92. PubMed ID: 12590318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer.
    Hwang SG; Kim KM; Cheong JH; Kim HI; An JY; Hyung WJ; Noh SH
    Eur J Surg Oncol; 2012 Jul; 38(7):562-7. PubMed ID: 22592098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
    Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.